Biodesix (BDSX) Return on Sales (2019 - 2026)

Biodesix has reported Return on Sales for 8 years, with the latest figure at 0.0% in Q1 2026.

• For the quarter ending Q1 2026, Return on Sales changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Sales for Q1 2026 stood at 0.0%, down from 0.0% in the prior quarter.
• The five-year high for Return on Sales was 0.0% in Q4 2025, with the low at 0.02% in Q1 2022.
• Historically, Return on Sales has averaged 0.01% across 5 years, with a median of 0.01% in 2023.
• The largest YoY upside for Return on Sales was 1 bps in 2022 against a maximum downside of 2 bps in 2022.
• Biodesix's Return on Sales stood at 0.02% in 2022, then surged by 63 bps to 0.01% in 2023, then jumped by 34 bps to 0.0% in 2024, then soared by 66 bps to 0.0% in 2025, then plunged by 129 bps to 0.0% in 2026.
• The last three Return on Sales figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.